Qiquan M. Chen
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Chronic Spontaneous Urticaria Combined Atopic Dermatitis/Other Atopic Comorbidities: Clinical Characteristics, Therapeutic Response to Omalizumab, and Drug Survival.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: May 29, 2026
Real-world outcomes of 24-week abrocitinib tapering in moderate-to-severe atopic dermatitis: Feasibility and regimen comparison.
Journal: Journal of the American Academy of Dermatology
Published: May 19, 2026
Efficacy and Safety of Tofacitinib in the Treatment of Refractory Chronic Spontaneous Urticaria: A Real-World Study.
Journal: Journal of the American Academy of Dermatology
Published: May 17, 2026
Clinical practice guideline for H1 antihistamine-resistant Chronic Spontaneous Urticaria.
Journal: Asian Pacific journal of allergy and immunology
Published: November 03, 2025
Predictors of Super/Poor Omalizumab Response in Chinese Refractory Chronic Spontaneous Urticaria.
Journal: Dermatology (Basel, Switzerland)
Published: November 02, 2025
Tofacitinib for the Treatment of Refractory Severe Acute Urticaria: A Retrospective Case Series.
Journal: American journal of therapeutics
Published: September 18, 2025
Characterizing Atopic Dermatitis and Abrocitinib Early Response Through Tape-Stripped and Serum Biomarkers.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: June 13, 2025
Both Extrinsic and Intrinsic Atopy in Chronic Spontaneous Urticaria Patients Indicate a Favorable Response to Omalizumab Treatment.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: May 21, 2025
Peripheral Blood ILC2s Levels Are Associated with Autoimmunity and Atopy in Chronic Spontaneous Urticaria: A Preliminary Study.
Journal: International archives of allergy and immunology
Published: May 05, 2025
Refractory chronic spontaneous urticaria with markedly elevated eosinophilia and pigmentation: diagnostic antiparasitic therapy breaks the therapeutic impasse.
Journal: Postepy dermatologii i alergologii
Published: May 03, 2025
Abrocitinib Treatment Modes: Impact on Prognosis and Relapse Rates in Atopic Dermatitis.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: April 02, 2025
Efficacy and Safety of UVA1 Phototherapy Adjunct Treatment for Acute Cutaneous Inflammations and Neuralgia of Herpes Zoster: A Prospective, Randomized, Open-Label, Blinded End-Point Study.
Journal: Photobiomodulation, photomedicine, and laser surgery
Published: January 09, 2025
Last Updated: 09/26/2026